Nerum SA
5.4 FTEThe score of Nerum shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +51 % Total assets +48 % Headcount (avg FTE) -5 %
Accounts of the company itself (not consolidated).
The full file covers 13 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Nerum's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 17 Jul 2024
- Year ended 31 Dec 2022filed on 28 Aug 2023
- Year ended 31 Dec 2021filed on 16 Jun 2022
Nerum's financial analysis
- Solvency88.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Nerum
Nerum's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0429.024.763
- VAT number
- BE0429024763
- Peppol
- Registered · 0208:0429024763 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 21 May 1986
- Registered office
- 3550 Heusden-Zolder
- Size
- Micro · 5.4 FTE
- Latest accounts
- 2025 · filed on 13 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Nerum (SA) has been based in Heusden-Zolder since 1986, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 760,408 € and equity of €5.70m; its revenue is not published. With 5.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 88.3%, above the median of its sector (44.2%).
Companies similar to Nerum
Companies in the same business, of comparable size and area, outside its group.
- Pharmalliance Retail sale of pharmaceutical products Lasne · balance sheet €6.38m
- Palatine Retail sale of pharmaceutical products Etterbeek · balance sheet €6.58m
- Farmathé Retail sale of pharmaceutical products Menen · balance sheet €7.37m
- Dermatheek Retail sale of pharmaceutical products Ranst · balance sheet €5.46m
- Apotheek Bourguignon-Deraeve Retail sale of pharmaceutical products Ninove · balance sheet €5.34m
- Apophar Retail sale of pharmaceutical products Ixelles · balance sheet €5.33m
- Alpaga MDB Retail sale of pharmaceutical products Kontich · balance sheet €5.32m
- Imbefrance Retail sale of pharmaceutical products Halle · balance sheet €5.11m
Frequently asked questions about Nerum
What is the revenue of Nerum?
Nerum files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Nerum?
In Belgium, the VAT number is the company number prefixed with BE: BE0429024763 for Nerum, if the company is VAT-registered. Its company number (CBE) is 0429.024.763.
Where is the registered office of Nerum?
According to the CBE register, the registered office of Nerum is in 3550 Heusden-Zolder.
What is the equity of Nerum?
At the close of the 2025 financial year, the equity of Nerum amounts to 5,702,814 €, a solvency of 88.3% of total assets.
How many people work at Nerum?
5.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Nerum?
The register lists 4 active mandates at Nerum. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Nerum
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →